Which super funds hold Coloplast A/S?

As at 31 December 2025, 12 Australian super investment options in our dataset held Coloplast A/S, the largest weighting being 0.00% in Balanced (Accumulation) (AustralianSuper).

Options holding it

12

Largest weighting

0.00%

Balanced (Accumulation) · AustralianSuper

Funds & options holding Coloplast A/S

Australian super investment options disclosing a holding in Coloplast A/S. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.

FundPhaseOptionWeightingValue (AUD)As at
AustralianSuperAccumulationBalanced (Accumulation)
0.00%
$1,530,61631 December 2025
AustralianSuperAccumulationHigh Growth (Accumulation)
0.00%
$343,68631 December 2025
AustralianSuperRetirementBalanced (Income)
0.00%
$202,70431 December 2025
AustralianSuperAccumulationInternational Shares (Accumulation)
0.00%
$179,92631 December 2025
AustralianSuperAccumulationIndex Diversified (Accumulation)
0.00%
$153,56831 December 2025
AustralianSuperRetirementIndex Diversified (Income)
0.00%
$69,84231 December 2025
AustralianSuperRetirementConservative Balanced (Income)
0.00%
$42,01831 December 2025
AustralianSuperAccumulationConservative Balanced (Accumulation)
0.00%
$34,65831 December 2025
AustralianSuperRetirementInternational Shares (Income)
0.00%
$26,79631 December 2025
AustralianSuperRetirementHigh Growth (Income)
0.00%
$23,25731 December 2025
AustralianSuperAccumulationStable (Accumulation)
0.00%
$14,49631 December 2025
AustralianSuperRetirementStable (Income)
0.00%
$13,35231 December 2025

This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.

Methodology — how holdings are sourced, resolved and aggregated.

LookThrough shows the actual holdings inside Australian super funds, with cross-fund look-through.

  • 4 of 86 funds
  • 36 of 111 options reviewed
  • 7,010 of 7,168 securities reviewed

© 2026 LookThrough. Factual disclosure information — not financial advice, a rating or a recommendation.